Aterian, Inc. current report, 13 September 2023

Full document

Aterian, Inc. Form 8-K Summary

Business Context and Reporting Period

Aterian, Inc. filed a Current Report on Form 8-K dated September 13, 2023, reporting amendments to the employment agreements of Joseph A. Risico, Co-Chief Executive Officer, and Arturo Rodriguez, Co-Chief Executive Officer and Chief Financial Officer. The report was signed on September 18, 2023.

Financial and Compensation Matters

  • Each executive’s base salary was increased to $325,000 per year.
  • Each executive received 945,946 restricted shares of common stock, or 1,891,892 shares in aggregate.
  • The restricted shares vest one-third on the first anniversary of the grant date and then in eight equal quarterly installments.
  • The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.

Material Changes, Outlook, and Contingencies

  • If either executive is terminated by the Company other than for Cause, subject to execution of a release, the executive is entitled to 12 months of base salary, up to 12 months of COBRA premium payments or until starting other employment, and acceleration of unvested equity awards.
  • Comparable benefits apply if a Change in Control occurs and the executive resigns for Good Reason within 12 months thereafter, subject to execution of a release.
  • The amendments may increase compensation expense, create potential equity dilution, and increase severance and equity-acceleration obligations.
  • No revenue or earnings guidance, business outlook, or operating-risk update was provided.
  • The full amendments were not included with this filing and were expected to be filed as exhibits to the Form 10-Q for the quarter ended September 30, 2023.

Key Facts for Investors to Verify

  1. Review the subsequent Form 10-Q exhibits for the complete employment-amendment terms and definitions of Cause, Good Reason, Change in Control, and release requirements.
  2. Assess the effect of the 1,891,892 restricted shares on outstanding shares, dilution, and future stock-based compensation expense.
  3. Verify the vesting schedules and whether any termination or change-in-control event has triggered accelerated vesting or severance obligations.
  4. Review later filings for changes to executive compensation, employment status, or related-party arrangements.